Bibliography
- Muirhead N. Management of idiopathic membranous nephropathy: evidence-based recommendations. Kidney Int 1999;55(Suppl 70):S47-55
- Ponticelli C. Membranous nephropathy. J Nephrol 2007;20:268-87
- D'Amico G. Influence of clinical and histological features on actuarial renal survival in adult patients with idiopathic IgA nephropathy, membranous nephropathy and membranoproliferative glomerulonephritis: survey of the recent literature. Am J Kidney Dis 1992;20:315-23
- Cattran DC. Frontiers in nephrology: membranous nephropathy. J Am Soc Nephrol 2005;16:1188-94
- Schieppati A, Mosconi L, Perna A, et al. Prognosis of untreated patients with idiopathic membranous nephropathy. N Engl J Med 1993;329:85-9
- Perna A, Schiepati A, Zamora J, et al. Immunosuppressive treatment for idiopathic membranous nephropathy: a systematic review. Am J Kidney Dis 2004;44:385-401
- Ponticelli C, Zucchelli P, Passerini P, et al. A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int 1995;48:1600-4
- Jha V, Ganguli A, Saha TK, et al. A randomized controlled trial of steroids and cyclophosphamide in adults with nephrotic syndrome caused by idiopathic membranous nephropathy. J Am Soc Nephrol 2007;18:1899-904
- Ponticelli C, Zucchelli P, Passerini P, Cesana B; and the Italian Idiopathic Membranous Nephropathy Treatment Study Group. Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. N Engl J Med 1992;327:599-603
- Ponticelli C, Altieri P, Scolari F, et al. A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. J Am Soc Nephrol 1998;9:444-50
- Cattran DC, Delmore T, Roscoe J, et al. A randomised controlled trial of prednisolone in idiopathic membranous nephropathy. N Engl J Med 1989;320:210-5
- Cameron JS, Healy MJR, Adu D. The Medical Research Council Trial of short-term high-dose alternate-day prednisolone in idiopathic membranous nephropathy with nephrotic syndrome in adults. The MRC Glomerulonephritis Working Party. Q J Med 1990;74:133-56
- Goumenos DS, Ahuja M, Davlouros P, et al. Prednisolone and azathioprine in membranous nephropathy. Clin Nephrol 2006;65:317-23
- Miller G, Zimmerman R, Radhakrishnan J, Appel G. Use of mycophenolate mofetil in resistant membranous nephropathy. Am J Kidney Dis 2000;36:250-6
- Choi MJ, Eustace JA, Gimenez LF, et al. Mycophenolate mofetil treatment for primary glomerular diseases. Kidney Int 2002;61:1098-14
- Ponticelli C, Passerini P, Salvadori N, et al. A randomized pilot trial comparing methylprednisolone plus a cytotoxic agent versus synthetic adrenocorticotropic hormone in idiopathic membranous nephropathy. Am J Kidney Dis 2006;47:233-40
- Ruggenenti P, Chiurchiu C, Abbate M, et al. Rituximab for idiopathic membranous nephropathy: who can benefit? Clin J Am Soc Nephrol 2006;1:738-48
- Fervenza FC, Cosio FG, Erickson SB, et al. Rituximab treatment of idiopathic membranous nephropathy. Kidney Int 2008;73:117-25
- Cattran DC, Alexopoulos E, Heering P, et al. Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome: workshop recommendations. Kidney Int 2007;72:1429-47
- Kshirsagar AV, Nachman PH, Falk RJ. Alternative therapies and future intervention for treatment of membranous nephropathy. Semin Nephrol 2003;23:362-72
- Halevy D, Radhakrishnan J. Cyclosporin treatment of glomerular diseases. Exp Opin Investig Drugs 2000;6:1053-63
- Guasch A, Suranyi M, Newton L, et al. Short-term responsiveness of membranous nephropathy to cyclosporin. Am J Kidney Dis 1992;20:472-81
- Zietse R, Wenting G, Kramer P, et al. Effects of cyclosporin A on glomerular barrier function in the nephrotic syndrome. Clin Sci 1992;82:641-50
- Ambalavanan S, Fauvel JP, Sibley RK, Myers BD. Mechanism of the antiproteinuric effect of cyclosporin in membranous nephropathy. J Am Soc Nephrol 1996;7:290-8
- Goumenos DS, Kalliakmani P, Tsakas S, et al. The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy. Clin Nephrol 2004;61:17-24
- De Santo NG, Capodicasa G, Giordano C. Treatment of idiopathic membranous nephropathy unresponsive to methylprednisolone and chlorambucil with cyclosporin. Am J Nephrol 1987;7:74-6
- Rostoker G, Belghiti DA, Remy P, et al. Long-term cyclosporin A therapy for severe idiopathic membranous nephropathy. Nephron 1993;63:335-41
- Fritsche L, Budde K, Farber L, et al. Treatment of membranous glomerulopathy with cyclosporin A: how much patience is required? Nephrol Dial Transplant 1999;14:1036-8
- Iida H, Naito T, Sakai N, Aoki S. Effect of cyclosporin therapy on idiopathic membranous nephropathy presented with refractory nephrotic syndrome. Clin Exp Nephrol 2000;4:81-5
- Cattran DC, Appel GB, Hebert LA, et al. for the North American Nephrotic Syndrome Study Group. Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial. Kidney Int 2001;59:1484-90
- Yao X, Chen H, Wang Q, et al. Cyclosporin A treatment for idiopathic membranous nephropathy. Chin Med J 2001;114:1305-8
- Cattran DC, Greenwood C, Ritchie S, et al.; for the Canadian Glomerulonephritis Study Group. A controlled trial of cyclosporine in patients with progressive membranous nephropathy. Kidney Int 1995;45:1130-5
- Goumenos DS, Katopodis K, Passadakis P, et al. Corticosteroids and cyclosporin-A in idiopathic membranous nephropathy: higher remission rate of nephrotic syndrome and less adverse reactions than the traditional treatment with cytotoxic drugs. Am J Nephrol 2007;27:226-31
- Alexopoulos E, Papagianni A, Tsamelashvili M, et al. Induction and long-term treatment with cyclosporin in membranous nephropathy with the nephrotic syndrome. Nephrol Dial Transplant 2006;21:3127-32
- Ponticelli C, Passerini P. The place of cyclosporin in the management of primary nephrotic syndrome. BioDrugs 1999;12:327-41
- Levy GA. C2 monitoring strategy for optimizing cyclosporin immunosuppression from the Neoral formulation. BioDrugs 2001;15:279-90
- Lindholm A, Kahan BD. Influence of cyclosporin pharmacokinetics, trough concentrations and AUC monitoring on outcome after kidney transplantation. Clin Pharmacol Ther 1993;54:205-18
- Goumenos DS, Kalliakmani P, Tsakas S, et al. Cyclosporin-A in the treatment of nephrotic syndrome: the importance of monitoring C0 (trough) and C2 (two hours after its administration) blood levels. Med Chem 2006;2:391-3
- Nakahata T, Tanaka H, Tsugawa K, et al. C1-C2 point monitoring of low-dose cyclosporin a given as a single daily dose in children with steroid-dependent relapsing nephrotic syndrome. Clin Nephrol 2005;64:258-63
- Mitsioni A, Siapera D, Elias A, et al. Second hour measurement of cyclosporin (C2) in children with nephrotic syndrome. Pediatric Nephrol 2002;17:c97
- Meyrier A, Noël L-H, Aurishe P, Callard P; the Collaborative Group of the Société de Néphrologie, with the technical assistance of Broneer D. Long-term renal tolerance of cyclosporin A treatment in adult idiopathic nephrotic syndrome. Kidney Int 1994;45:1446-56
- Zucchelli P, Pascuali S, Casanova S, Donini U. Clinical and morphological evolution of idiopathic membranous nephropathy. Clin Nephrol 1986;25:282-8
- Pierides AM, Malasit P, Morley AR, et al. Idiopathic membranous nephropathy. Q J M 1977;XLVI 182:163-77
- Kalliakmani P, Goumenos D, Koutroulia E, et al. Repeated renal biopsies in cyclosporine treated patients with idiopathic membranous nephropathy and remission of nephrotic syndrome. XLII Congress of EDTA, Instaboul, Turkey. Nephrol Dial Transplant 2005;(Suppl 5):228
- Schwartz MM. Membranous GN. Heptinstall's pathology of the kidney. 5th edition. Philadelphia: Lippincott-Raven; 1998;1:259-307
- Rasche FM, Keller F, Kunze G, et al. Single daily dose of cyclosporine in patients with primary glomerulonephritis and nephrotic syndrome. Clin Nephrol 2007;67:285-92
- Praga M, Barrio V, Juarez GF, Luno J. Tacrolimus monotherapy in membranous nephropathy: a randomised controlled trial. Kidney Int 2007;71:924-30